Manns Braden J, Mendelssohn David C, Taub Kenneth J
Department of Medicine, University of Calgary, Calgary, T2N 2T9, AB, Canada.
Int J Health Care Finance Econ. 2007 Sep;7(2-3):149-69. doi: 10.1007/s10754-007-9022-y.
Examining international differences in health outcomes for end-stage renal disease (ESRD) patients requires an understanding of ESRD funding structures. In Canada, funding for all aspects of dialysis and transplant care, with the exception of drugs (for which supplementary insurance can be purchased), is provided for all citizens. Although ESRD programs across Canada's 10 provinces differ in funding structure, they share important economic characteristics, including being publicly funded and universal, and providing most facets of ESRD care for free. This paper explains how ESRD care fits into the Canadian health care system, describes the epidemiology of ESRD in Canada, and offers economic explanations for international discrepancies.
研究终末期肾病（ESRD）患者健康结局的国际差异需要了解ESRD的资金结构。在加拿大，为所有公民提供透析和移植护理各方面的资金，但药品除外（药品可购买补充保险）。尽管加拿大10个省的ESRD项目在资金结构上存在差异，但它们具有重要的经济特征，包括由公共资金资助且具有普遍性，并且免费提供ESRD护理的大多数方面。本文解释了ESRD护理如何融入加拿大医疗保健系统，描述了加拿大ESRD的流行病学，并对国际差异提供了经济解释。
